Table 1 Distribution of the study sample and prevalence of positive antibodies for SARS-CoV-2, according to sociodemographic characteristics and region.

From: High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2

 

Sample distribution

% of positive tests

Number

%

Region

Northeast

9982

31.3%

6.2%

North

5180

16.3%

4.1%

Central-West

3603

11.3%

0.9%

Southeast

8021

25.1%

0.4%

South

5083

16.0%

0.7%

Sex

Female

18,646

58.5%

2.7%

Male

13,223

41.5%

2.6%

Age (years)

0–4

637

2.0%

4.6%

5–9

862

2.7%

2.7%

10–19

2789

8.8%

1.9%

20–29

4965

15.6%

2.4%

30–39

4999

15.7%

3.0%

40–49

5078

15.9%

2.8%

50–59

5032

15.8%

3.0%

60–69

4234

13.3%

2.6%

70 + 

3273

10.3%

2.1%

Color/ethnicity

White

11,442

36.7%

1.3%

Brown

14,131

45.4%

3.5%

Black

4264

13.7%

2.9%

Asian

897

2.9%

3.0%

Indigenous

429

1.4%

6.3%

Schooling

Primary or less

11,417

39.3%

2.8%

Secondary

11,363

39.1%

2.8%

University or higher

6275

21.6%

1.4%

Wealth quintiles

Poorest

7668

24.1%

3.3%

2nd

5809

18.2%

3.3%

3rd

6334

19.9%

2.8%

4th

6214

19.5%

2.4%

Richest

5844

18.3%

1.4%

  1. The EPICOVID19 study, third wave.